Allocation concealment

Allocation Concealment

Allocation concealment is a critical methodological feature in randomized controlled trials (RCTs) that prevents selection bias by ensuring that the assignment of participants to treatment groups remains unpredictable before enrollment.

Why Allocation Concealment Matters

1. Prevents Selection Bias

• Without concealment, researchers or participants may (intentionally or unintentionally) influence group assignment.
• Example: If an investigator knows the next participant will receive the treatment, they may selectively enroll healthier participants, skewing results.

2. Maintains Randomization Integrity

• Ensures that randomization is implemented as intended.
• Prevents systematic differences between treatment and control groups, preserving comparability at baseline.

3. Enhances Trial Credibility

• Trials without proper concealment are at high risk of bias.
• Regulatory agencies (e.g., FDA, EMA) and peer-reviewed journals require appropriate concealment for trial acceptance.

4. Reduces Performance and Detection Bias

• Knowledge of group assignments may influence participant treatment (performance bias).
• It may also affect outcome measurement and reporting (detection bias).

5. Supports Ethical Research Practices

• Promotes fairness and transparency in participant allocation.
• Maintains equipoise and protects the ethical conduct of the trial.

Best Methods for Allocation Concealment

• Centralized randomization – via web-based or telephone systems (IWRS/IVRS) managed independently of trial staff.
• Sequentially numbered, opaque, sealed envelopes (SNOSE) – with tamper-proof, pre-prepared assignments.
• Computer-generated codes – held and released by an independent statistician or data center.

Conclusion

Allocation concealment is essential for preventing bias, preserving randomization, and ensuring the scientific and ethical integrity of RCTs.

Bibliography

1. Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. The Lancet. 2002;359(9306):614–618.
2. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.
3. Higgins JPT, Thomas J, Chandler J, et al. (editors). Cochrane Handbook for Systematic Reviews of Interventions, version 6.3 (updated February 2022). Cochrane; 2022. Chapter 8: Assessing risk of bias in a randomized trial.
4. Devereaux PJ, Choi PT, El-Dika S, et al. An observational study found that authors of randomized controlled trials frequently use the term allocation concealment incorrectly. Journal of Clinical Epidemiology. 2005;58(7):662–664.

Read about Implementing allocation concealment

---

Adapted for educational use. Please cite relevant trial methodology sources when using this material in research or teaching.